Lipopolysaccharides IgA+IgM

Optimal result: 0 – 2.6 ELISA Index

Lipopolysaccharides (LPS) is the compound in the membranes of harmful bacteria that trigger inflammation. Immune cells in the mucosal lining do not interact with LPS unless the walls are breached due to leaky gut. Upon exposure, the immune system produces antibodies to LPS, another marker we can measure to identify leaky gut. LPS antibodies also signify gut flora dysbiosis, or the overgrowth of harmful bacteria in the digestive tract. When we see LPS antibodies in the bloodstream we know it is causing inflammation throughout the body and may have breached the blood-brain barrier, causing inflammation in the brain.

Clinical Significance:

Lipopolysaccharides (LPS) are bacterial endotoxins that elicit a strong immune response. The detection of salivary antibodies against LPS indicates mucosal immune reactivity to LPS. Upregulated antibodies to LPS indicate gut dysbiosis. If the patient is experiencing recent-onset high fever, weakness and stomach pains, or has bloody diarrhea, the elevated salivary LPS may be an indication of Typhoid fever or Escherichia coli infection respectively.

In an S typhi LPS study, researchers found the level of salivary anti-LPS IgA was significantly higher in typhoid cases compared to febrile and healthy control and also revealed that the maximum sensitivity of salivary anti-LPS IgA are in the second and third weeks of illness, with the levels falling thereafter.

Salivary IgA and IgM antibodies were found to decline to their normal levels 45 to 90 days after the acute phase. Studies on Escherichia coli infections showed greater specificity and sensitivity of salivary IgA over serum antibodies during the acute phase of hemolytic uremic syndrome.

Lipopolysaccharide (LPS) is a molecule made up of a lipid and a polysaccharide. LPS is a component of the surface membrane of gram-negative bacteria found in the gastrointestinal tract. Gram-negative bacteria include: Escherichia coli, Salmonella, Shigella, Pseudomonus, Helicobactor, Legionella, Wolbachia. As an endotoxin, LPS increases the negative charge of the bacterial membrane and promotes the upregulation of pro-inflammatory cytokines.

Lipopolysaccharides (LPS) are endotoxins from gram-negative bacteria in the gut. The LPS protects gram-negative bacteria from gram-positive bacteria. When gram-negative bacterium dies it releases its LPS, which travels through the epithelial cells of the intestinal barrier and finds its way into the blood stream. Once LPS reaches the blood stream, it causes inflammation throughout the body and has been implicated in playing a role in multiple disorders.

- When Lipopolysaccharides (LPS) enter the bloodstream, it can contribute to plaque formation in the arteries leading to heart disease and has been implicated in metabolic, liver, thyroid, bone and nervous system disorders.
- LPS can also open the blood-brain barrier and put the brain and nervous system at risk.

Antibodies Appear:

→ Gram-negative bacterial infection

→ Hemolytic uremic syndrome

→ Increase intestinal permeability

→ Typhoid fever

Known Cross-Reactions:

DNA-histone, Ganglioside, Antiphospholipid antibodies

References:

- Ludwig, et al. Saliva IgM and IgA are a sensitive indicator of the humoral immune response to Escherichia coli O157 lipopolysaccharide in children with enteropathic hemolytic uremic syndrome. Pediatr Res, 2002; 52:307–313.

- Chart, et al. Analysis of saliva for antibodies to the LPS of Escherichia coli O157 in patients with serum antibodies to E. coli O157 LPS. J Med Microbiol, 2003, 52:569–572.

- Herath. Early diagnosis of typhoid fever by the detection of salivary IgA. J Clin Pathol, 2003;56:694–648.

- Maes, et al. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuroendocrinol Lett, 2008; 29(1):117-124.

- Neisser, et al. Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher Syndrome. Infect Immunity, 1997; 65(10):4038-4042.

- Poxton, et al. Antibodies to lipopolysaccharide.Immunol Methods, 1995; 186:1-15.

- Sumazaki, et al. Monoclonal antibody against bacterial lipopolysaccharide cross-reacts with DNA-histone. Clin exp Immunol, 1986; 66:103-110.

- Zaka-ur-Rab, et al. Evaluation of salivary anti-Salmonella typhi lipopolysaccharide IgA ELISA for serodiagnosis of typhoid fever in children. Arch Dis Child, 2012; 97(3):236-238.

- Cheng, et al. IgA antiphospholipid antibodies in normal human saliva cross-react with bacterial lipopolysaccharide. Int Arch Allergy Immunol, 1993; 101:297-298.

Lipopolysaccharides IgA+IgM
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Lipopolysaccharides IgA+IgM — 10,000+ markers explained
One Lipopolysaccharides IgA+IgM result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro